<DOC>
	<DOCNO>NCT03083665</DOCNO>
	<brief_summary>The purpose study evaluate efficacy brivaracetam ( BRV ) compare placebo ( PBO ) adjunctive treatment Asian subject ( &gt; =16 80 year age ) partial seizure without secondary generalization despite current treatment 1 2 concomitant antiepileptic drug ( AEDs ) ass safety tolerability BRV subject &gt; = 16 year 80 year age .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Adjunctive Brivaracetam Asian Subjects ( &gt; =16 80 Years Age ) With Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Subjects ( male female ) 16 80 year age Visit 1 , inclusive . Subjects legal adult may include legally permit ethically accept . Female subject childbearing potential eligible use medically accept contraceptive method . Wellcharacterized focal epilepsy/epileptic syndrome accord 1989 International League Against Epilepsy ( ILAE ) classification . Presence electroencephalogram ( EEG ) read compatible clinical diagnosis focal epilepsy within last 5 year . Presence brain magnetic resonance imaging ( MRI ) /computed tomography ( CT ) scan perform within last 2 year . Subjects least 8 partial seizure ( accord 1981 ILAE classification ) 8Week Baseline Period least 2 partial seizure 4week interval Baseline Period . Subjects least 2 partial seizure whether secondary generalization per month 3 month precede Visit 1 . Subjects uncontrolled treat 1 2 permit concomitant antiepileptic drug [ AED ] ( ) . Vagal Nerve Stimulation ( VNS ) allow count concomitant AED . Permitted concomitant AED ( ) VNS stable optimal dosage subject least 4 week ( 12 week phenobarbital , phenytoin , primidone ) Visit 1 expect keep stable whole study period . Subject history presence status epilepticus year precede Visit 1 Baseline . Subject history cerebrovascular accident , include transient ischemic attack , last 24 week . Subject history presence know psychogenic nonepileptic seizure .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Partial seizure without secondary generalization</keyword>
	<keyword>Brivaracetam</keyword>
	<keyword>Asian subject</keyword>
</DOC>